Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;41(1):3-11.
doi: 10.33176/AACB-19-00035.

The Pursuit of Value in Laboratory Medicine - Progress and Challenges

Affiliations
Review

The Pursuit of Value in Laboratory Medicine - Progress and Challenges

Andrew St John. Clin Biochem Rev. 2020 Feb.

Abstract

The pressure on healthcare budgets including laboratory medicine is relentless and the focus on activities and costs remains the dominant funding model of laboratory medicine everywhere. The limitations of this model are well documented and for a decade or more laboratory professions worldwide have started looking at alternative models where the value of laboratory medicine and its impact on patient outcomes are the predominant driving force. There are multiple ways to determine the value of a medical test, particularly if one takes into consideration its impact upon the complete clinical pathway. Thus various approaches to value determination are being explored by a number of international organisations. These organisations will be reviewed below, including one which uses the concept of a value proposition that describes in detail how a test should be implemented by measuring its clinical, operational and economic impact. All approaches for determination of value require professional leadership. There is a need for research of varying types including that related to translating global evidence into local practice, a key challenge facing laboratory medicine and healthcare generally. Another challenge is to think and act beyond the silo of the laboratory to achieve greater collaboration with those colleagues more directly involved in patient care.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None declared.

Figures

Figure 1
Figure 1
Complete process from biomarker discovery through test evaluation to adoption and implementation of routine testing.
Figure 2
Figure 2
Vitamin D test requests at an Australian pathology practice by month from 2014–2017.
Figure 3
Figure 3
Process of development of Clinical Decision Support (CDS) software for test requesters. (Supplied courtesy of Ken Sikaris, Sonic Healthcare, Melbourne, Australia.)

References

    1. Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–81. - PubMed
    1. Roland M, Sibbald B, McDonald R. Care closer to home. Moving care. Health Serv J. 2007;117(Suppl):6–8. - PubMed
    1. Lundberg GD. The need for an outcomes research agenda for clinical laboratory testing. JAMA. 1998;280:565–6. - PubMed
    1. St John A, Edwards G, Fisher S, Badrick T, Callahan J. Crothers J. A call for a value based approach to laboratory medicine funding. Clin Biochem. 2015;48:823–6. - PubMed
    1. Sikaris KA. Enhancing the clinical value of medical laboratory testing. Clin Biochem Rev. 2017;38:107–14. - PMC - PubMed

LinkOut - more resources